|
HDAC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.978100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.135240E-03 |
| Normal-vs-Stage2 |
5.207400E-01 |
| Normal-vs-Stage3 |
7.858600E-01 |
| Normal-vs-Stage4 |
7.577000E-01 |
| Stage1-vs-Stage2 |
3.431400E-01 |
| Stage1-vs-Stage3 |
4.299700E-02 |
| Stage1-vs-Stage4 |
4.828100E-02 |
| Stage2-vs-Stage3 |
7.161200E-01 |
| Stage2-vs-Stage4 |
5.028200E-01 |
| Stage3-vs-Stage4 |
6.590200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.139770E-02 |
| Normal-vs-AfricanAmerican |
3.461800E-02 |
| Normal-vs-Asian |
9.446400E-01 |
| Caucasian-vs-AfricanAmerican |
9.950200E-01 |
| Caucasian-vs-Asian |
3.671600E-01 |
| AfricanAmerican-vs-Asian |
2.771000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.000830E-03 |
| Normal-vs-Female |
9.336000E-01 |
| Male-vs-Female |
5.599200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.850430E-02 |
| Normal-vs-Extreme_Weight |
3.875200E-03 |
| Normal-vs-Obese |
8.646100E-02 |
| Normal-vs-Extreme_Obese |
6.216500E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.285400E-01 |
| Normal_Weight-vs-Obese |
3.802800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.232600E-01 |
| Extreme_Weight-vs-Obese |
2.262800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.220600E-01 |
| Obese-vs-Extreme_Obese |
1.657640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.131000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.785800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.017100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.548500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.223800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.323800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.382400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.753350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.205600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.993600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.780500E-04 |
| Normal-VS-Type2 PRCC |
8.608800E-01 |
| Normal-VS-KIRP CIMP |
4.613400E-01 |
| Normal-VS-Unclassified PRCC |
3.517800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.856880E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.185400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.145610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.759000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.676200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.739600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.264100E-02 |
| Normal-vs-N1 |
8.725200E-01 |
| Normal-vs-N2 |
4.312800E-01 |
| N0-vs-N1 |
1.084580E-01 |
| N0-vs-N2 |
6.962200E-02 |
| N1-vs-N2 |
3.283200E-01 |
|
|
